| 发明名称 |
LIQUID FORMULATION COMPRISING CETUXIMAB AND A FATTY ACID ESTER OF POLYOXYETHYLENE SORBITAN |
| 摘要 |
The invention relates to a stable liquid pharmaceutical formulation comprising Cetuximab(R), a chimeric monoclonal antibody against the receptor of endothelial growth factor (EGF receptor). The formulation has increased storage stability and can be used parenterally for the treatment of tumours. |
| 申请公布号 |
PL364599(A1) |
申请公布日期 |
2004.12.13 |
| 申请号 |
PL20020364599 |
申请日期 |
2002.06.18 |
| 申请人 |
MERCK PATENT GMBH |
发明人 |
MAHLER HANNS-CHRISTIAN;MUELLER ROBERT;MARTINI-MARR ULRIKE;HAAS UDO;BACHMANN CHRISTIANE |
| 分类号 |
A61K9/08;A61K31/429;A61K39/395;A61K47/02;A61K47/04;A61K47/34;A61P35/00;C07K16/28 |
主分类号 |
A61K9/08 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
